Correlation Between Apimeds Pharmaceuticals and Clearside Biomedical

Can any of the company-specific risk be diversified away by investing in both Apimeds Pharmaceuticals and Clearside Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apimeds Pharmaceuticals and Clearside Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Apimeds Pharmaceuticals US, and Clearside Biomedical, you can compare the effects of market volatilities on Apimeds Pharmaceuticals and Clearside Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apimeds Pharmaceuticals with a short position of Clearside Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apimeds Pharmaceuticals and Clearside Biomedical.

Diversification Opportunities for Apimeds Pharmaceuticals and Clearside Biomedical

0.13

Correlation Coefficient

Apimeds Pharmaceuticals  Clearside Biomedical

Average diversification

The 3 months correlation between Apimeds and Clearside is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Apimeds Pharmaceuticals US, and Clearside Biomedical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clearside Biomedical and Apimeds Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apimeds Pharmaceuticals US, are associated (or correlated) with Clearside Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clearside Biomedical has no effect on the direction of Apimeds Pharmaceuticals i.e., Apimeds Pharmaceuticals and Clearside Biomedical go up and down completely randomly.

Pair Corralation between Apimeds Pharmaceuticals and Clearside Biomedical

Given the investment horizon of 90 days Apimeds Pharmaceuticals US, is expected to generate 11.65 times more return on investment than Clearside Biomedical. However, Apimeds Pharmaceuticals is 11.65 times more volatile than Clearside Biomedical. It trades about 0.08 of its potential returns per unit of risk. Clearside Biomedical is currently generating about -0.07 per unit of risk. If you would invest  0.00  in Apimeds Pharmaceuticals US, on September 13, 2025 and sell it today you would earn a total of  208.00  from holding Apimeds Pharmaceuticals US, or generate 9.223372036854776E16% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	31.34%
Values	Daily Returns

Apimeds Pharmaceuticals US,  vs.  Clearside Biomedical

Apimeds Pharmaceuticals

Risk-Adjusted Performance

Soft

Compared to the overall equity markets, risk-adjusted returns on investments in Apimeds Pharmaceuticals US, are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively inconsistent basic indicators, Apimeds Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Clearside Biomedical

Risk-Adjusted Performance

Weakest

Over the last 90 days Clearside Biomedical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2026. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Apimeds Pharmaceuticals and Clearside Biomedical

The main advantage of trading using opposite Apimeds Pharmaceuticals and Clearside Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apimeds Pharmaceuticals position performs unexpectedly, Clearside Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clearside Biomedical will offset losses from the drop in Clearside Biomedical's long position.

The idea behind Apimeds Pharmaceuticals US, and Clearside Biomedical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .